Kayne Anderson Rudnick Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$208K Sell
8,566
-126,353
-94% -$3.06M ﹤0.01% 499
2025
Q1
$3.42M Sell
134,919
-66,379
-33% -$1.68M 0.01% 297
2024
Q4
$5.34M Sell
201,298
-531,663
-73% -$14.1M 0.01% 264
2024
Q3
$21.2M Buy
732,961
+35,454
+5% +$1.03M 0.05% 191
2024
Q2
$19.5M Sell
697,507
-22,242
-3% -$622K 0.05% 204
2024
Q1
$20M Sell
719,749
-324,900
-31% -$9.02M 0.05% 199
2023
Q4
$30.1M Sell
1,044,649
-1,559
-0.1% -$44.9K 0.08% 166
2023
Q3
$34.7M Sell
1,046,208
-62,296
-6% -$2.07M 0.1% 150
2023
Q2
$40.7M Buy
1,108,504
+61,948
+6% +$2.27M 0.11% 144
2023
Q1
$42.7M Buy
1,046,556
+446,618
+74% +$18.2M 0.13% 133
2022
Q4
$30.7M Buy
599,938
+36,724
+7% +$1.88M 0.1% 154
2022
Q3
$24.6M Buy
563,214
+143,008
+34% +$6.26M 0.08% 165
2022
Q2
$22M Sell
420,206
-63,957
-13% -$3.35M 0.07% 173
2022
Q1
$25.1M Sell
484,163
-9,722
-2% -$503K 0.07% 177
2021
Q4
$29.2M Sell
493,885
-6,527
-1% -$385K 0.07% 178
2021
Q3
$21.5M Sell
500,412
-19,301
-4% -$830K 0.05% 185
2021
Q2
$20.4M Buy
519,713
+12,291
+2% +$481K 0.05% 190
2021
Q1
$18.4M Buy
507,422
+177,837
+54% +$6.44M 0.05% 189
2020
Q4
$12.1M Sell
329,585
-10,154
-3% -$374K 0.04% 218
2020
Q3
$11.8M Buy
339,739
+151,788
+81% +$5.29M 0.04% 207
2020
Q2
$5.83M Buy
187,951
+117,239
+166% +$3.64M 0.02% 217
2020
Q1
$2.19M Buy
70,712
+20,408
+41% +$632K 0.01% 250
2019
Q4
$1.87M Buy
50,304
+17,649
+54% +$656K 0.01% 278
2019
Q3
$1.11M Buy
32,655
+12,820
+65% +$437K 0.01% 290
2019
Q2
$815K Buy
19,835
+10,250
+107% +$421K ﹤0.01% 300
2019
Q1
$386K Buy
+9,585
New +$386K ﹤0.01% 317